Arcus Biosciences (RCUS) Common Equity (2017 - 2026)
Arcus Biosciences (RCUS) posted Common Equity of $464 million for Q2 2026, down 15.5% from $549 million a year earlier and down 11.5% from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Common Equity (2017 - 2026) Analysis & Trends
At the end of FY2025, Arcus Biosciences' Common Equity came in at $631 million, up 30.1% from FY2024.
- Annual Common Equity shows a five-year compound annual growth rate of 4.7% (FY2020 to FY2025).
- In prior years, Arcus Biosciences' Common Equity was $485 million in FY2024 (+5.0%), $462 million in FY2023 (-29.7%), $657 million in FY2022 (-22.0%) and $842 million in FY2021 (+67.7%).
- Quarterly Common Equity has run from a low of $436 million in Q3 2025 to a high of $842 million in Q4 2021 over five years.
- On a year-over-year basis, Common Equity increased in three of the last eight quarters, with an average decline of 4.3%.
- The strongest year-over-year quarter for Common Equity in the past five years was Q4 2021, with growth of 67.7%; the weakest was Q4 2023, with a decline of 29.7%.
- According to Business Quant data, Common Equity for the three prior quarters was $524 million (Q1 2026), $631 million (Q4 2025) and $436 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Arcus Biosciences | 3.18 Bn | -157.19 Mn | - | 464.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 464.00 Mn |
| Mar 31, 2026 | 524.00 Mn |
| Dec 31, 2025 | 631.00 Mn |
| Sep 30, 2025 | 436.00 Mn |
| Jun 30, 2025 | 549.00 Mn |
| Mar 31, 2025 | 531.00 Mn |
| Dec 31, 2024 | 485.00 Mn |
| Sep 30, 2024 | 565.00 Mn |
| Jun 30, 2024 | 635.00 Mn |
| Mar 31, 2024 | 707.00 Mn |
| Dec 31, 2023 | 462.00 Mn |
| Sep 30, 2023 | 520.00 Mn |
| Jun 30, 2023 | 566.00 Mn |
| Mar 31, 2023 | 600.00 Mn |
| Dec 31, 2022 | 657.00 Mn |
| Sep 30, 2022 | 699.00 Mn |
| Jun 30, 2022 | 747.00 Mn |
| Mar 31, 2022 | 797.00 Mn |
| Dec 31, 2021 | 842.00 Mn |
| Sep 30, 2021 | 542.61 Mn |
API Access
Arcus Biosciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();